Tag : NT-proBNP

Despite being an established biomarker for heart failure, the utility of N-terminal pro-B-type natriuretic peptide (NT-proBNP) in identifying broader complications, such as cardiorenal dysfunction, has remained underexplored. This knowledge gap, particularly within Asian populations, has limited the ability of clinicians to stratify risk and intervene early in patients at the highest risk of adverse outcomes. A retrospective cohort study utilizing the Hong Kong Diabetes Biobank (HKDB), led by researchers from the Department of Medicine and Therapeutics, The Chinese University of Hong Kong (CUHK) found NT-proBNP as a reliable biomarker for predicting cardiovascular and renal complications in patients with type 2 diabetes (T2DM).